Ioflupane I-123

(DaTscan®)

Ioflupane I-123

Drug updated on 11/16/2023

Dosage FormInjection (intravenous; 74 MBq (2 mCi)/mL)
Drug ClassMultiple
Ongoing and
Completed Studies
ClinicalTrials.gov

Indication

  • Indicated for striatal dopamine transporter visualization using single photon emission computed tomography (SPECT) brain imaging to assist in the evaluation of adult patients with suspected Parkinsonian Syndromes (PS). It helps differentiate essential tremor from tremor due to PS (idiopathic Parkinson's disease, multiple system atrophy and progressive supranuclear palsy).
  • As an adjunct to other diagnostic evaluations.